"St. Catherine Hospital is a regional health care center that provides a full-range of medical specialties and exceptional health care in southwest Kansas."

During the past decade, Saint Catherine Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 29 clinical trials were completed, i.e. on average, 93.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 27 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Catherine Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Catherine Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Saint Catherine Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Recurrent Breast Carcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "Saint Catherine Hospital" in a lesser frequency.

Most popular intervention types in "Saint Catherine Hospital" are "Drug" (39 trials), "Other" (37 trials), "Biological" (18 trials), "Procedure" (11 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Quality-of-Life Assessment" (9 trials), "Nivolumab" (7 trials), "Placebo Administration" (7 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Saint Catherine Hospital" are 42 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Catherine Hospital". undefined are not yet recruiting, 4 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Saint Catherine Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saint Catherine Hospital, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".